Altria Group Inc
NYSE: MO
$50.04
-$0.19 (-0.4%)
Real Time Data Delayed 15 Min.
MO Articles
Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney and Wells Fargo.
Published:
If investors have learned one thing over time, it is that it can be very painful when a company announces that it is cutting its dividend. 24/7 Wall St. has screened out 10 stocks that have dividends...
Published:
With new e-cigarette lawsuits, Juul is anything but the jewel in the Altria crown.
Published:
Altria’s attempts to diversify have soured and its stock is lagging, but the company has pricing power and pays a solid dividend.
Published:
Counting out a tobacco company has never proved to be a good bet over the long term. Will this time be different?
Published:
Cigarette smoking is falling out of favor but Altria could still appeal to investors as it looks to tobacco alternatives.
Published:
Altria wants to diversify into e-cigarettes and legal pot, but faces regulatory action, patent litigation and coronavirus-related setbacks.
Published:
U.K. tobacco giant Imperial Brands has slashed its dividend. Will American tobacco companies follow suit?
Published:
Last Updated:
When the economy began to face an instant recession from the coronavirus, even before the name COVID-19 became labeled a pandemic, the phenomena of buying defensive stocks was thrown out the window....
Published:
Altria's share price is falling. Its investments have been busts, and hedge funds and shareholders are getting cranky. Even the dividend hasn't made investors happy.
Published:
Altria’s investments in Juul and Cronos Group weigh on investor sentiment even though core tobacco business looks strong.
Published:
COVID-19 has already beaten up tobacco giant Altria but things may be getting even worse as Juul, in which it has a stake, is facing fresh problems.
Published:
Altria Group Inc. investors will want to note the latest setbacks for e-cigarette manufacturer Juul Labs, which include regulatory troubles, adverse publicity around the health effects of vaping, and...
Published:
With investments in booze, pot, tobacco and e-cigarettes, Altria has the sin category just about covered. However, the COVID-19 outbreak may indicate that the cost of sin has limits.
Published:
A combination of financial factors creates an interesting value proposition for investors as Altria reports later this week. Also, we will get a chance to see if anything happens with the dividend.
Published: